drugset / Trial / NCT02249871

Investigating the Influence of Omeprazole on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects

NCT02249871

Phase 1 Completed 54 enrolled Novo Nordisk A/S
RandomizedParallel-groupOpen-labelTreatment

Summary

This trial is conducted in Europe. The aim of this trial is to investigate the influence of omeprazole on the pharmacokinetics (the exposure of the trial drug in the body) of oral semaglutide in healthy subjects.

Timeline

Start
2014-09-24
Primary completion
2015-04-01
Completion
2015-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Omeprazole Other / unclassified 40 mg
Subject Semaglutide Peptide 10 mg Oral

Indications